Promega Ireland’s Post

United States In-Vitro Diagnostics Market Insights 2024-2029: Increasing Adoption Of Automation in Laboratories and … [ Research ]

Check out Key Tech Inc.‘s approach for evaluating assays for automation! If you're developing an IVD device or life science tool, this #Framework is definitely worth referencing. https://lnkd.in/d6GFiYdr Originally written in 2021 & geared to de-risking platforms, we tend to view it now from a more positive, market-launch perspective. How can you step-change your consumable or instrument cost, differentiate from competition, and successfully exit to a strategic? I like thinking about it more positively 😃 Give it a read and see for yourself! #AssayAutomation #LifeScience #IVD #KeyTechInc

In our latest article for ONdrugDelivery, Biomedical Market Manager Landon Goldfarb highlights the challenges of autoinjector testing and the importance of drawing on the experience of customers when it comes to drug delivery device innovation: https://lnkd.in/dk4CAHzg

By reducing the size of drug particles, #nanoforming can open up new opportunities – from increasing bioavailability to enabling sustained drug delivery. Discover the potential benefits supported by case studies. https://lnkd.in/eK5BDcBp Source: Nanoform #drugdelivery #bioavailability

Unpacking Laboratory Equipment Trends: A Booming Market The laboratory equipment market is on an impressive growth trajectory, poised to leap from a global value of $35 billion in 2023 to over $50 billion by 2030. Key drivers include the burgeoning need for diagnostic testing, heightened R&D investments, and advancements in the biotech and healthcare sectors. #LifeSciences #Innovation #LabEquipment #LifeSciencesRecruitment

🧫 Enhancing Biopharma Productivity with In-Line Monitoring Solutions 🔬 Last Hamilton Process Analytics webinar showcased groundbreaking sensor technologies, and you can still catch all the insights on-demand! 🎥 Watch the full webinar now and see how in-line VCD measurement can be a game-changer for your processes: https://lnkd.in/eGTqsDQ7 👉 In this highlighted user case, a mAb pilot plant in the USA tackled productivity head-on using our Viable Cell Density (VCD) technology. By implementing in-situ, in-line monitoring of cell density, they could control automated feeding strategies more effectively. 💡 The result? A substantial increase in yield, proving the value of precise, real-time data. 📈 This is just one of the many real-world applications where our sensor technology excels, enhancing process analytics and outcomes. ▶️ Discover how Hamilton's pioneering approach to process analytics can elevate your operations. #Biopharma #Incyte #ViableCellDensity #ProcessOptimization #HamiltonWebinar #OnDemand #BiotechInnovation #ProcessAnalytics #HamiltonCompany

Microplate Systems Market on the Rise! 📈 📥 Download Complete PDF: https://lnkd.in/die4SrmG The global microplate systems market is projected to grow from USD 927 million in 2021 to USD 1,170 million by 2026, with a compound annual growth rate (CAGR) of 4.8%! Microplate systems are essential in advancing applications like drug discovery and clinical diagnostics. This market covers a range of products, including: - Microplate Readers (multi-mode, single-mode) - Microplate Washers - Accessories 🔬 As demand for high-throughput and precision-based testing rises, hospitals, diagnostic laboratories, and research centers are expanding their reliance on these technologies, driving growth globally. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Danaher Corporation Bio-Rad Laboratories PerkinElmer Thermo Fisher Scientific Agilent Technologies Tecan BMG LABTECH Promega Corporation Enzo Life Sciences, Inc. Berthold Technologies Biochrom Ltd. Corning Incorporated Lonza DYNEX Technologies Greiner Bio-One International Accuris CTK Biotech, Inc. LTEK Jasco Biohit Oyj Mindray Hudson Robotics, Inc. #MicroplateSystems #HealthcareInnovation #Diagnostics #LifeSciences #MarketGrowth #DrugDiscovery #ClinicalDiagnostics

With a focus on the individual you can concentrate care options for the best results. See how Michael and his company's approach to patient-centric care has changed the landscape of the biomedical manufacturing world.

Can biomedical innovators actually be patient-centric? Does it require an altogether more pateint-centric ecosystem? Clinical trials, regulatory, care settings...supply chains? Michael Chiu outlines the approach to a more patient-centric manufacturing ecosystem as envisioned by Erbi Biosystems, a part of MilliporeSigma.

Can biomedical innovators actually be patient-centric? Does it require an altogether more pateint-centric ecosystem? Clinical trials, regulatory, care settings...supply chains? Michael Chiu outlines the approach to a more patient-centric manufacturing ecosystem as envisioned by Erbi Biosystems, a part of MilliporeSigma.